Pharmaceutical News

RSS

Optimization of drug dose sizes can reduce pharmaceutical wastage

Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College London in the UK, shows that by optimizing drug dose sizes available, wastage can be cut by as much as 50 percent.

6 Dec 2018

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018.

5 Dec 2018

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.

From Bristol-Myers Squibb 5 Dec 2018

Study investigates influence of different opioids on driving performance

Taking opioids for the treatment of pain has been associated with increased risks of crashing among drivers, but it is unknown whether this applies to all opioids or pertains to specific opioids only.

5 Dec 2018

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah--the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.

5 Dec 2018

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor in combination with an oral anticoagulant.

4 Dec 2018

Study finds omitted medicine to be the most common medication administration errors

Medication administration errors leading to death are common with anticoagulants and antibiotics in particular, according to a new study that analyzed incidents reported in England and Wales.

4 Dec 2018

Consumption of antibiotics for children varies widely from country to country, finds study

Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the types of antibiotics.

4 Dec 2018

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and effective.

4 Dec 2018

One-quarter of patients with diabetes report using less insulin due to high costs

For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States.

3 Dec 2018

Study examines whether taking multiple medications for heart failure can limit abilities in older adults

As we age, we tend to develop a number of chronic health conditions and concerns. Often, managing health problems can mean that older adults may take many different medications. When older adults take five or more medicines (a scenario health experts call "polypharmacy", it can increase the risk of harmful side effects.

3 Dec 2018

Cannabis prescribed medicinally to the first patient in UK

A 32 year old woman – Carly Barton, has been suffering from a long term painful condition called fibromyalgia. This was after a stroke she had suffered from in her twenties. In a new development, she became the first patient United Kingdom to have been prescribed medical cannabis after a change in the laws.

3 Dec 2018

Researchers uncover genes that lead to excessive tau in dementia

Researchers have identified two major groups of genes involved in the mutations that lead to excess production of tau, a protein involved in dementia.

3 Dec 2018

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications.

3 Dec 2018

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the "2018 Shunde Biomedical Industry Investment Promotion Conference" which ran in parallel with the Precision Medicine and Ion Channel Retreat was successfully held at the Ramada Plaza Hotel, Shunde, Guang Dong, China.

3 Dec 2018

FDA approves new combination therapy for acute myeloid leukemia

Older patients with acute myeloid leukemia (AML) often aren't healthy enough to receive intensive chemotherapy, and gentler treatments aren't very effective in treating this aggressive blood cancer.

30 Nov 2018

First-of-its-kind undertaking to study genetic, biological factors that contribute to development of opioid use disorder

The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction).

29 Nov 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

Gel formulation of a new male contraceptive on trial

The National Institutes of Health (NIH) is funding a clinical trial to see the safety and effectiveness of a new male contraceptive that would be available in gel formulation.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Pharmaceutical News

Optimization of drug dose sizes can reduce pharmaceutical wastage

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

Study investigates influence of different opioids on driving performance

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Study finds omitted medicine to be the most common medication administration errors

Consumption of antibiotics for children varies widely from country to country, finds study

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

One-quarter of patients with diabetes report using less insulin due to high costs

Study examines whether taking multiple medications for heart failure can limit abilities in older adults

Cannabis prescribed medicinally to the first patient in UK

Researchers uncover genes that lead to excessive tau in dementia

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

FDA approves new combination therapy for acute myeloid leukemia

First-of-its-kind undertaking to study genetic, biological factors that contribute to development of opioid use disorder

FDA approves new drug for treatment of rare autoimmune disorder

Gel formulation of a new male contraceptive on trial

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News